Workflow
MENGNIU DAIRY(CIADY)
icon
Search documents
蒙牛乳业(02319.HK)9月1日回购50.00万股,耗资758.13万港元
| 日期 | 回购股数(万股) | 回购最高价(港元) | 回购最低价(港元) | 回购金额(万港元) | | --- | --- | --- | --- | --- | | 2025.09.01 | 50.00 | 15.190 | 15.140 | 758.13 | | 2025.08.29 | 22.80 | 15.370 | 15.210 | 348.33 | | 2025.08.28 | 30.00 | 16.000 | 15.810 | 477.69 | | 2025.07.25 | 20.00 | 17.280 | 17.020 | 343.33 | | 2025.07.24 | 20.00 | 17.300 | 17.240 | 345.45 | | 2025.07.23 | 20.00 | 17.560 | 17.500 | 351.09 | | 2025.07.22 | 20.00 | 17.200 | 17.180 | 343.67 | | 2025.07.21 | 20.00 | 17.120 | 17.060 | 342.07 | | 2025.07.18 | 20.00 | 16. ...
蒙牛乳业(02319)9月1日斥资758.13万港元回购50万股
Zhi Tong Cai Jing· 2025-09-01 10:06
智通财经APP讯,蒙牛乳业(02319)发布公告,于2025年9月1日斥资758.13万港元回购50万股股份。 该信 息由智通财经网提供 ...
蒙牛乳业(02319.HK)9月1日耗资758万港元回购50万股
Ge Long Hui· 2025-09-01 10:00
格隆汇9月1日丨蒙牛乳业(02319.HK)发布公告,2025年9月1日耗资758万港元回购50万股。 ...
蒙牛乳业9月1日斥资758.13万港元回购50万股
Zhi Tong Cai Jing· 2025-09-01 09:57
蒙牛乳业(02319)发布公告,于2025年9月1日斥资758.13万港元回购50万股股份。 ...
蒙牛乳业(02319) - 翌日披露报表
2025-09-01 09:51
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 中國蒙牛乳業有限公司 呈交日期: 2025年9月1日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02319 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前 ...
建银国际:蒙牛(02319)持续股份回购可支持估值 维持“跑赢大市”评级
智通财经网· 2025-09-01 09:33
智通财经APP获悉,建银国际发布研报称,蒙牛乳业(02319)拥有强劲现金流,可为2025至2027年间50% 股息分派比率提供支持,而持续股份回购亦可支持估值。该行调整蒙牛目标价至20.7港元,维持"跑赢 大市"评级。 ...
蒙牛乳业(02319) - 董事名单与其角色和职能
2025-09-01 09:31
CHINA MENGNIU DAIRY COMPANY LIMITED 中國蒙牛乳業有限公司* (於開曼群島注册成立的有限公司) (股份代號:2319) 董事名單與其角色和職能 中國蒙牛乳業有限公司董事會(「董事會」)成員載列如下: 執行董事 高飛先生(總裁) 沈新文先生 王燕女士 非執行董事 慶立軍先生(主席) 孟凡傑先生 Lillie Li VALEUR 女士 獨立非執行董事 葉禮德先生 李恒健先生 葛俊先生 董事會已設立五個董事委員會。下表載有各董事會成員在這些委員會中擔任的職位。 | 董事 | 董事委員會 | 審核委員會 | 提名委員會 | 薪酬委員會 | 戰略及發展 | 可持續發展 | | --- | --- | --- | --- | --- | --- | --- | | | | | | | 委員會 | 委員會 | | 高飛先生 | | | | | 成員 | 成員 | | 沈新文先生 | | | | | 成員 | | | 王燕女士 | | | | | | 成員 | | 慶立軍先生(主席) | | | 委員會主席 | | 委員會主席 | | | 孟凡傑先生 | | | | | 成員 | | | L ...
蒙牛乳业(02319):经营利润率同比提升,静待供需好转
Xinda Securities· 2025-08-31 09:33
Investment Rating - The investment rating for the company is not explicitly stated in the provided documents, but the report suggests a cautious outlook with expectations of revenue decline and stable operating profit margins [1][3]. Core Viewpoints - The company experienced a revenue decline of 6.95% year-on-year in the first half of 2025, with total revenue reaching RMB 415.67 billion. However, operating profit increased by 13.43% to RMB 35.38 billion, while net profit attributable to shareholders decreased by 16.37% to RMB 20.46 billion [1][3]. - The liquid milk segment faced pressure due to lower demand, leading to a revenue drop of 11.22%, while other segments like ice cream, milk powder, and cheese saw revenue growth of 15.40%, 2.47%, and 12.28% respectively [3]. - The company is diversifying its product structure and responding to market changes by launching various temperature-stable liquid milk products and collaborating with emerging channels for customized products [3]. - The company’s gross profit margin improved to 41.7%, up 1.4 percentage points year-on-year, primarily due to a decrease in raw milk prices. Operating profit margin also increased significantly by 1.5 percentage points to 8.5% [3]. - The company is positioned at the bottom of its valuation range over the past five years, with expectations for a recovery in supply and demand conditions to drive valuation improvement [3]. Financial Summary - For the first half of 2025, the company reported a revenue of RMB 415.67 billion, a decrease of 6.95% year-on-year. The operating profit was RMB 35.38 billion, an increase of 13.43%, while the net profit attributable to shareholders was RMB 20.46 billion, down 16.37% [1][3]. - The projected net profits for 2025, 2026, and 2027 are RMB 42.79 billion, RMB 49.40 billion, and RMB 56.66 billion respectively, with corresponding P/E ratios of 13X, 11X, and 10X [3][4]. - The company’s gross margin is expected to remain stable at around 40.20% for the upcoming years, with a slight increase in net profit margin projected [4].
蒙牛乳业(2319.HK):终端复苏仍有不确定性 管理层下调指引
Ge Long Hui· 2025-08-30 19:04
Group 1 - The company's revenue decreased by 4% in volume and low single digits in price, resulting in a total revenue of 41.57 billion RMB, with a year-on-year decline in net profit attributable to shareholders of 16.4% to 2.05 billion RMB [1] - Despite revenue pressure, the company's profitability improved, with gross margin increasing by 1.4 percentage points to 41.7% due to falling raw milk prices, and operating profit margin rising by 1.5 percentage points to 8.5% [1] - The management indicated that terminal demand remains weak, expecting a continued decline in volume and price in the second half of the year, leading to a downward revision of the full-year guidance [1] Group 2 - The core liquid milk business saw a revenue decline of 11.2% to 32.19 billion RMB, reflecting weak terminal demand and intense price competition, while other categories like ice cream (+15.0%), cheese (+12.3%), and milk powder (+2.5%) showed positive growth [2] - The cheese business benefited from synergies with Miaokelan, expanding into snack and family meal scenarios, while infant formula experienced double-digit growth, indicating a positive trend [2] - Management aims for an annual improvement of 30-50 basis points in operating profit margin over the next three years, despite the current weak terminal demand [2] Group 3 - The company has lowered its revenue forecasts for 2025-2027 by 8-14% due to the performance in the first half and the recent weak terminal demand, with uncertainty surrounding the recovery of liquid milk sales [2][3] - Based on more conservative operating profit margin predictions, the company has adjusted its profit forecasts for 2025-2027 down by 11-19% for operating profit and 9-27% for net profit attributable to shareholders [3] - The target price has been revised down to 21.51 HKD based on a 15 times expected price-to-earnings ratio for 2026, while maintaining a buy rating [3]
蒙牛乳业(02319.HK):液奶需求承压 聚焦产品创新及渠道升级
Ge Long Hui· 2025-08-30 19:04
Core Viewpoint - The company's 1H25 performance is in line with expectations, with a revenue decline of 6.9% year-on-year and a net profit drop of 16.4% primarily due to losses from joint ventures [1][2]. Financial Performance - Revenue for 1H25 was 41.57 billion yuan, with a year-on-year decrease of 6.9% - Net profit attributable to shareholders was 2.05 billion yuan, down 16.4% year-on-year - Operating profit margin (OPM) increased by 1.5 percentage points year-on-year [1][2]. Segment Performance - Liquid milk, ice cream, milk powder, and cheese revenues changed by -11.2%, +15%, +2.5%, and +12.3% respectively - The decline in liquid milk revenue was attributed to weak consumer confidence and demand, leading to a price reduction for certain products to enhance distributor profitability [1][2]. Strategic Focus - The company is focusing on product innovation and channel strategy upgrades to counteract weak demand - New product launches include prebiotic and vitamin-enriched milk, with initial success in expanding partnerships with membership supermarkets and snack retailers [1][3]. Profitability and Cost Management - Gross margin improved by 1.4 percentage points year-on-year due to lower raw milk prices - Sales expense ratio decreased by 0.5 percentage points, while management expenses increased due to factory shutdown costs and higher R&D investments [2][3]. Future Outlook - The company aims to maintain a focus on product innovation and channel adaptation to mitigate sales pressure in the second half of 2025 - Long-term goals include enhancing the industrial chain and deep processing, with an expected annual OPM increase of 30-50 basis points over the next 3-5 years [3]. Earnings Forecast and Valuation - Earnings forecasts for 2025 and 2026 have been revised down by 19% and 9% to 4.2 billion yuan and 5.2 billion yuan respectively - The current trading multiples are 13.4x and 10.8x for 2025 and 2026 P/E, with a target price of 23 HKD, indicating a potential upside of 45% [3].